Loading…
ARIKAYCE is an amikacin liposome inhalation suspension for adults with refractory MAC lung disease who remain culture positive after at least six months of multidrug therapy. It is used as part of a combination antibacterial regimen to achieve and sustain sputum culture conversion.
We haven’t found ARIKAYCE in the AI answers we’ve checked.
